Skip to main content
SpringerLink
Log in

Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects

  • Published:
Journal of Inherited Metabolic Disease

Summary

We report two infants identified by tandem mass spectrometry (MS/MS) of neonatal blood spot acylcarnitines and confirmed by molecular genetic analysis to have long-chain fatty acid oxidation defects. In both cases, acylcarnitine concentrations in confirmatory plasma samples were normal. None the less, molecular testing identified trifunctional protein (TFP) deficiency (McKusick 600890) and very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency (McKusick 201475).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Harvard Medical School, Boston, Massachusetts

    M. F. Browning & D. L. Marsden

  2. Children’s Hospital Boston, Boston, Massachusetts

    M. F. Browning & D. L. Marsden

  3. New England Newborn Screening Program, Jamaica Plain, Massachusetts

    C. Larson

  4. Vanderbilt Children’s Hospital, Nashville, Tennessee, USA

    A. Strauss

  5. Department of Metabolism, Fegan 10, Children’s Hospital Boston, 300 Longwood Avenue, Boston, MA, 02115, USA

    M. F. Browning

Authors
  1. M. F. Browning
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Larson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Strauss
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. L. Marsden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. F. Browning.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Browning, M.F., Larson, C., Strauss, A. et al. Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects. J Inherit Metab Dis 28, 545–550 (2005). https://doi.org/10.1007/s10545-005-0545-4

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-005-0545-4

Keywords

Search

Navigation